Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
A patient on warfarin or a direct oral anticoagulant who takes an excess BPC-157 dose could theoretically experience additive bleeding risk
GLP-1 compounds work through gut hormones
Potential risks Serious risks and adverse events include: Allergic reaction to the medications or dye used in the injection Shoulder infection Depigmentation of the skin around the injection site (a whitening of the skin) Local fat atrophy around the injection site (thinning of the skin) Rupture of a tendon located in the path of the injection Nerve damage near the shoulder joint Bleeding at the injection site In addition to the above, corticosteroid injections increase the risk of: High blood pressure High blood sugar Decreased immune function Decrease in bone mineral density Bone infection (osteonecrosis) Reproductive hormone imbalance Metabolic changes (eg, increased appetite, weight gain, and fluid retention) These risks are typically associated with higher doses of corticosteroids, multiple injections, and for people with underlying medical conditions such as diabetes and heart problems
Tolerance, a term meaning that after continued drinking, increasing amounts of alcohol are necessary to produce the same effect, does not have an effect on the actual BAC.
Results in the external validation set were similar
